Brief Report: Challenges in Obtaining the Informed Perspectives of Stakeholders Regarding HIV Molecular Epidemiology.
Brief Report: Challenges in Obtaining the Informed Perspectives of Stakeholders Regarding HIV Molecular Epidemiology.
复制标题
简要报告:获取利益相关者有关艾滋病毒分子流行病学的知情观点的挑战。
DOI:
10.1097/qai.0000000000003179
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Sugarman,Jeremy
中科院分区:
文献类型:
--
作者:
Bollinger,JuliM;Geller,Gail;May,Elizabeth;Brewer,Janesse;Henry,LeslieMeltzer;Sugarman,Jeremy
Background:HIV molecular epidemiology (HIV-ME) is now being used in a variety of ways, including molecular HIV surveillance to help identify and respond to emerging HIV transmission clusters as specified in the Ending the HIV Epidemic in the US initiative. However, HIV-ME in general, and its use for cluster detection and response, in particular, raises significant ethical and social concerns, which have spurred vigorous debates. Nevertheless, there is a paucity of information regarding how these potential benefits and concerns are perceived among people living with HIV and people without HIV at an increased risk.Setting:Virtual engagement with US participants.Methods:We rigorously developed a brief informational video about HIV-ME and conducted a series of in-depth interviews with people living with HIV and people without HIV at an increased risk.Results:Through extensive stakeholder engagement during the video development process and subsequent in-depth interviews (N= 24), several preliminary findings surfaced. In contrast to the high level of concern raised by some critics of HIV-ME, our data appear to show broad support for it. In addition, we observed conflation of perspectives about HIV-ME with concerns about HIV public health surveillance more generally.Conclusion:Our experiences reveal substantial communication challenges related to the nature of HIV-ME that need to be overcome to ensure that it is properly understood, which is necessary for meaningfully engaging stakeholders in discussions about its use. Moreover, ongoing, responsive, engagement efforts are critical. Additional systematic data are needed to help inform policy making and practice regarding HIV-ME.